The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor
Abstract
The escape of malignant cells from the immune response against the tumor may result from a defective differentiation or function of professional antigen-presenting cells (APC), ie, dendritic cells (DC). To test this hypothesis, the effect of human renal cell carcinoma cell lines (RCC) on the development of DC from CD34(+) progenitors was investigated in vitro. RCC cell lines were found to release soluble factors that inhibit the differentiation of CD34(+) cells into DC and trigger their commitment towards monocytic cells (CD14(+)CD64(+)CD1a-CD86(-)CD80(-)HLA-D Rlow) with a potent phagocytic capacity but lacking APC function. RCC CM were found to act on the two distinct subpopulations emerging in the culture at day 6 ([CD14(+)CD1a-] and [CD14(-)CD1a+]) by inhibiting the differentiation into DC of [CD14(+)CD1a-] precursors and blocking the acquisition of APC function of the [CD14(-)CD1a+] derived DC. Interleukin-6 (IL-6) and macrophage colony-stimulating factor (M-CSF) were found to be responsible for this phenomenon: antibodies against IL-6 and M-CSF abrogated the inhibitory effects of RCC CM; and recombinant IL-6 and/or M-CSF inhibited the differentiation of DC similarly to RCC CM. The inhibition of DC differentiation by RCC CM was preceeded by an induction of M-CSF receptor (M-CSFR; CD115) and a loss of granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR; CD116) expression at the surface of CD34(+) cells, two phenomenon reversed by anti-IL-6/IL-6R and anti-M-C…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CSF-2 in isolation also promotes their differentiation into a dendritic cell lineage, which maintains a phagocytic phenotype (CD68 immunopositive) [17, 30].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [30]
Citations
Cites
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,659
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Caux, C., Dezutter‐Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,551
Self-citationSchwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,245
Caux, C., Vanbervliet, B., Massacrier, C., Dezutter‐Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.695 · Cited by 920
Self-citationZitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.1.87 · Cited by 824
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.
Zhou, L., & Tedder, T. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3821 · Cited by 751
Kawasaki, E. S., Ladner, M. B., Wang, A. M., Arsdell, J. V., Warren, M. K., Coyne, M. Y., Schweickart, V. L., Lee, M.-T., Wilson, K. J., Boosman, A., et al. (1985) · Science · doi:10.1126/science.2996129 · Cited by 523
Research works printed but not linked: 1
- Négrier, 1996, The FNCLCC CRECY trial: Interleukin 2 (IL2) + interferon (IFN)-α is the optimal treatment to induce responses in metastatic renal cell carcinoma (MRCC)., Proc Am Soc Clin Oncol, 15, 248
Cited by
Sorted by citations
Items 501–590 of 590
Protumorigenic Function of Dendritic Cells
Kukreja, A. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_17 · Cited by 2
Reduction of liver metastases outgrowth by tumour antigen-pulsed dendritic cell vaccination
Mels, A. K., Mayen, I., van Egmond, M., Beelen, R. H. J., Meijer, S., & Richters, C. D. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s54 · Cited by 2
Myeloid-Derived Suppressor Cells in Tumor-Induced T Cell Suppression and Tolerance
Serafini, P., & Bronte, V. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_4 · Cited by 2
Malfunction of the Dendritic Cell System in Cancer
Yurkovetsky, Z. R., Tourkova, I. L., Balkir, L., Perez, L., Shurin, G. V., Chatta, G. S., & Shurin, M. R. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-743-7_3 · Cited by 2
Cellules dendritiques et gliomes : un espoir en immunothérapie ?
Jouanneau, E., Poujol, D., Caux, C., Belin, M., Blay, J., Puisieux, I., & Puisieux, I. (2006) · Neurochirurgie · doi:10.1016/s0028-3770(06)71367-4 · Cited by 2
Self-citationMoretti, A. (2011) · TSpace (University of Toronto) · Cited by 2
Zhang, X., Li, F., Zhang, J., Tang, Y. C., Xiao, B., Wan, Y., & Jiang, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/708826 · Cited by 2
Tumor-Derived Factors Responsible for Dendritic Cell Dysfunction
Pinzón‐Charry, A., & López, J. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_7 · Cited by 1
Elimination of Dendritic Cells in Cancer
Umansky, V., & Schadendorf, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_6 · Cited by 1
Prophylactic Vaccination of Cancer Patients and Hematopoietic Stem Cell Transplant Recipients
Decker, W. K., & Safdar, A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_50 · Cited by 1
Autoantibodies and Biomarker Discovery
Qiu, J., & Anderson, K. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394446-7.00023-6 · Cited by 1
Alzhrani, R. F., Xu, H., Valdes, S. A., Naguib, Y. W., & Cui, Z. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100441 · Cited by 1
Novel Therapeutic Approaches for Neuroblastoma
Joshi, S., Alok, R., Lisa, L. R., Zulcic, M., Ahn, H., & Donald, L. (2013) · InTech eBooks · doi:10.5772/55451 · Cited by 2
Polarisation of Macrophage and Immunotherapy in the Wound Healing
Wu, Y.-S., Nan, F., Chen, S., & Chen, S. (2016) · InTech eBooks · doi:10.5772/63478 · Cited by 1
Randolph, G. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012455851-9/50060-2 · Cited by 1
Identification and characterization of genes with specific expression in dendritic cells
Heinz, S. (2003) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.10104 · Cited by 1
Macrophages in tumour development and metastasis
Eichten, A., de Visser, K. E., & Coussens, L. M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6729-7_8 · Cited by 1
DCs in lymphoma — biology and therapeutic aspects
Schultze, J. L., Fiore, F., & von Bergwelt‐Baildon, M. (2004) · Cytotherapy · doi:10.1080/14653240410006095 · Cited by 1
Immune modulation by cow’s milk components : Implications for respiratory health
Perdijk, O. (2018) · doi:10.18174/457213 · Cited by 1
Bacteria-mediated anti-cancer therapy
Bhave, M. S. (2019) · doi:10.32657/10220/47828 · Cited by 1
The Use of Human Dendritic Cell Subsets in Cancer Vaccines
Sweere, J. M. (2011) · Utrecht University Repository (Utrecht University)
Effects of IL-2 Immunomodulation on Infectious Complications in Colorectal Surgery
Nespoli, A., Brivio, F., Fattori, L., Valerio, M., Nespoli, L. C., Arsena, V., Corso, V., & Totis, M. (2002) · Springer eBooks · doi:10.1007/978-94-017-0637-7_3
Investigating the role of PD-L1 pathway in human ovarian cancer
Chatterjee, J. (2014) · doi:10.25560/25119
Higham, E. M., Wittrup, K. D., & Chen, J. (2010) · DSpace@MIT (Massachusetts Institute of Technology)
Natural killer cells in cancer : studies on migration and cytotoxicity
Wennerberg, E. (2014) · Figshare
Rosborough, B. R. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Torchia, G. (2008) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/1847
da Silva, A. S. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2007.tde-16082010-114023
Bittner, P. M. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.15229
Neuroblastoma as a target for effector mechanisms of the immune system
Geer, A. D. (2007) · Figshare
Scheller, N. (2006) · Publications of the UdS (Saarland University) · doi:10.22028/d291-20854
van Cruijsen, H. (2009) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Heinz, L. X., Platzer, B., Reisner, P. M., Taschner‐Mandl, S., & Strobl, H. (2016)
Myeloid derived suppressor cells in patients with Pancreatic Adenocarcinoma
Khaled, Y. S. (2014) · [Thesis]. Manchester, UK: The University of Manchester; 2014.
COMBINATIONAL CYTOKINE THERAPY OF CANCER: PLEIOTROPIC IMPACT WITHIN THE TUMOR MICROENVIRONMENT
Berhanu, A. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Dendritic cell dysfunction and implications for dendritic cell-based therapy in colorectal cancer
Josiassen, M. V., & Paulsson, K. M. (2011) · Drugs and Therapy Studies · doi:10.4081/dts.2011.e14
Wojas‐Krawczyk, K., Hus, I., Dmoszyńska, A., & Milanowski, J. (2009)
Transcriptional and signalling mechanisms during dendritic cell differentiation and maturation
Corbí, A. L., Puig‐Kröger, A., & de Investigaciones, C. S. (2002)
Tumour-Induced Immune Suppression by Myeloid Cells
Zilio, S., Desantis, G., Chioda, M., & Bronte, V. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_4
Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts
Bol, K. F., Schreibelt, G., Aarntzen, E. H. J. G., de Vries, I. J. M., & Figdor, C. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_4
The role of myeloid cells in breast cancer metastasis
Swierczak, A. (2012) · Minerva Access (University of Melbourne)
Bawa, M. S. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28335
Review Advances of MUC1 as a target for breast cancer immunotherapy
Yang, E., & Xing, P. (2007)
O microambiente supressor no câncer: efeitos locais e sistêmicos em monócitos de pacientes.
Ramos, R. N. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2016.tde-06052016-153849
Stem Cells and Hematopoietic Cell Engineering
Xie, X., Li, Y., Sun, Y., Zhang, J. C., Fang, F., Yue, W., & Pei, X. (2015) · Translational medicine research · doi:10.1007/978-94-017-7273-0_5
Investigating the role of the PD-1 pathway in human ovarian cancer
Maine, C. J. (2010) · doi:10.25560/5578
Hebbar, M., Preisser, P., Anegón, I., Catala, L., Ifrah, N., Descamps, P., Gamelin, E. C., Duluc, D., Delneste, Y., Tan, F., et al. (2007)
Predictors of Response to Immune Checkpoint Blockade
Andrews, M. C., & Wargo, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_31
Eixo IL-4/STAT-6/SOCS-5 na diferenciação das células dendríticas: efeitos da melatonina.
de Oliveira, A. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2018.tde-02022018-110610
Ager, C. R. (2018) · Digital Commons-TMC (Texas Medical Center)
Blay, J. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31004-0
Self-citationSulindac decreases basal-like mammary tumor burden and pro-inflammatory mediators in obese mice
Khatib, S. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/6gha-rv57
THE ROLE OF INTRATUMORAL DENDRITIC CELLS IN THE PROGRESSION OF SQUAMOUS CELL CARCINOMAS
Bondar, L. N., Таширева, Л. А., Савенкова, О. В., Чойнзонов, Е. Л., & Михайлович, П. В. (2019) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2019-18-4-50-58
Functional Biomaterials Modulate Macrophage in the Tumour Micro-environment
Wu, T., Wang, K.-T., Tsai, H.-L., Nan, F., & Wu, Y. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92429
Gascan, H., Hebbar, M., Jeannin, P., Preisser, L., Anegón, I., Catala, L., Ifrah, N., Descamps, P., Duluc, D., Delneste, Y., et al. (2013)
Strobl, H., Platzer, B., Jörgl, A., Taschner‐Mandl, S., Heinz, L. X., & Reisner, P. M. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch3
(2001) · Elsevier eBooks · doi:10.1016/b978-012455851-9/50085-7
Using Natural Adjuvants to Stimulate Anti-Tumour Immune Responses
Kuhn, S. P. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17011490
Berthier‐Vergnes, O., Gaucherand, M., Navarro, J., Schmitt, D., Mj, S., Plouët, J., & Pageaux, J.-F. (2001) · British Journal of Cancer · doi:10.1038/sj/bjc/6692183
Prakash, H. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87474
于, 彬. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.132176
Bharadwaj, U., Li, M., Zhang, R., Chen, C., & Yao, Q. (2023) · doi:10.1158/0008-5472.c.6495788
Bharadwaj, U., Li, M., Zhang, R., Chen, C., & Yao, Q. (2023) · doi:10.1158/0008-5472.c.6495788.v1
Hu, H., & Zhang, M. (2024) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2023e13192
Palmer, O., Perreard, L., Kolling, F., Pioli, P. A., & Goods, B. A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5242142
Kajiyama, S., Nagatake, T., Ishikawa, S., Hosomi, K., Shimada, Y., Matsui, Y., & Kunisawa, J. (2024) · Figshare · doi:10.6084/m9.figshare.26609133
Influence of hypoxia on tumour cell susceptibility to cytotoxic T lymphocyte mediated lysis
Noman, M. Z. (2012) · theses.fr (ABES) · doi:10.70675/306da2eez5bc3z478ez83c5zdc39407a896e
Djenidi, B. F. (2014) · theses.fr (ABES) · doi:10.70675/82393e4dz1433z4905zbff8zb3e7e5008e64
Modulation of the innate immune response by the oncoviruses EBV and HPV
Parroche, P. (2011) · theses.fr (ABES) · doi:10.70675/1123b896zdfdaz408az9372z41cc116e27df · Cited by 2
Impact de l’acide lactique sur le phénotype et le métabolisme des macrophages humains
Paolini, L. (2018) · theses.fr (ABES) · doi:10.70675/1588aa66z8794z4b07z9a33z8b26f2ceafa4
Dumont, A. (2018) · theses.fr (ABES) · doi:10.70675/01e0a564z8829z4bebz978bz17aa7a43cb26
Single cell multi-OMICS analysis of Treg biology in cancer
Richer, W. (2021) · theses.fr (ABES) · doi:10.70675/97f429e9z2993z4b78z88dezf46fae0d3a30
Hagege, A. (2022) · theses.fr (ABES) · doi:10.70675/de357a08zde04z4690z8b75z8f2bd3f595b4
Glioma microenvironment: Cellular crosstalk, immunosuppression, and novel therapeutic perspectives
Hu, Y., Liang, J., Xu, J., & Zhao, L. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004151
Hammami, I. (2011) · PolyPublie (École Polytechnique de Montréal)
Etude des populations immunitaires régulatrices et inflammatoires dans les cancers colorectaux
Tosolini, M. (2010) · HAL
Metadata
- Authors
- Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y.
- Affiliations
- From Unité Cytokine et Cancer, Unité INSERM 453, Centre Léon Bérard, Lyon, France; and Schering Plough, Dardilly, France.
- Inserm (FR)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-12-15
- Volume
- 92
- Issue
- 12
- Pages
- 4778-4791
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W193748226
- Cited by
- 590
- References
- 48
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 9 · 2020: 20 · 2019: 16 · 2018: 13 · 2017: 9 · 2016: 25 · 2015: 26 · 2014: 19 · 2013: 30 · 2012: 25
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell differentiation, CD34+ progenitors, renal cell carcinoma, tumor immune evasion, interleukin-6, macrophage colony-stimulating factor, M-CSF receptor, GM-CSF receptor, antigen-presenting cells, monocyte differentiation, CD1a, CD14, soluble factors
- MeSH terms
- Antibodies, Carcinoma, Renal Cell, Cell Differentiation, Cell Division, Dendritic Cells, Dose-Response Relationship, Drug, Gene Expression Regulation, Humans, Lymphokines, Tumor Cells, Cultured, Interleukin-6, Immunophenotyping, Macrophage Colony-Stimulating Factor, Receptor, Macrophage Colony-Stimulating Factor, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Endothelial Growth Factors, Culture Media, Conditioned, Antigens, CD34, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Cell Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review